LLY

1,123.15

+1.83%↑

JNJ

242.36

+2.73%↑

ABBV

235.91

+1.55%↑

UNH

406.13

-0.19%↓

NVS

154.24

+1.45%↑

LLY

1,123.15

+1.83%↑

JNJ

242.36

+2.73%↑

ABBV

235.91

+1.55%↑

UNH

406.13

-0.19%↓

NVS

154.24

+1.45%↑

LLY

1,123.15

+1.83%↑

JNJ

242.36

+2.73%↑

ABBV

235.91

+1.55%↑

UNH

406.13

-0.19%↓

NVS

154.24

+1.45%↑

LLY

1,123.15

+1.83%↑

JNJ

242.36

+2.73%↑

ABBV

235.91

+1.55%↑

UNH

406.13

-0.19%↓

NVS

154.24

+1.45%↑

LLY

1,123.15

+1.83%↑

JNJ

242.36

+2.73%↑

ABBV

235.91

+1.55%↑

UNH

406.13

-0.19%↓

NVS

154.24

+1.45%↑

Search

West Pharmaceutical Services Inc

Cerrado

SectorSanidad

335.99 2

Resumen

Variación precio

24h

Actual

Mínimo

325

Máximo

336.26

Métricas clave

By Trading Economics

Ingresos

6.7M

139M

Ventas

40M

845M

P/B

Media del Sector

44.079

49.712

BPA

2.13

Rentabilidad por dividendo

0.26

Margen de beneficios

16.428

Empleados

10,800

EBITDA

9M

219M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+13.13% upside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

0.26%

2.36%

Próximas Ganancias

23 jul 2026

Fecha Próximo Dividendo

5 ago 2026

Próxima Fecha de Ex Dividendo

29 jul 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

3.3B

23B

Apertura anterior

333.99

Cierre anterior

335.99

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

143 / 342 Clasificación en Healthcare

West Pharmaceutical Services Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Acerca de West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat